These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2929149)

  • 1. [The somatotropic hormone and liver diseases].
    Weber P; Martínek K; Cechácek Z
    Vnitr Lek; 1989 Jan; 35(1):36-42. PubMed ID: 2929149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Somatotropic hormone in the serum of diabetics].
    Dobrev D; Manolov D; Vakov L
    Vutr Boles; 1981; 20(2):49-53. PubMed ID: 7257332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of somatotropic hormone with post-infarction myocardial remodelling and clinical prognosis in patients with myocardial infarction].
    Tepliakov AT; Telkova IL; Karpov RS
    Klin Med (Mosk); 2001; 79(2):37-41. PubMed ID: 11419083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the hypophyseal somatotropic hormone (STH) levels in cancer patients].
    Vereshchagina GV; Kharchenko VP; Sutiagin AG
    Vopr Onkol; 1983; 29(6):28-33. PubMed ID: 6868474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
    Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
    Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic markers of chronic liver disease].
    de Marquez ML; Tombazzi C; Camacho G; Mata M; Carvajal R; Lecuna V
    G E N; 1995; 49(1):1-6. PubMed ID: 8566666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatotropin and prolactin levels in patients with insulin-dependent diabetes mellitus].
    Golikova AA
    Probl Endokrinol (Mosk); 1984; 30(1):8-11. PubMed ID: 6709609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the lipid profile in chronic hepatopathies].
    Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
    Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secretion of somatotropic hormone in patients with pancreatitis].
    Gidaiatov AA; Abasov IT; Aliev MG; Guseĭnov ShG
    Ter Arkh; 1986; 58(2):105-6. PubMed ID: 3518116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of hyperglobulinemia in severe chronic liver diseases--with special reference to the correlation between serum globulin/IgG level and ICG clearance.
    Tanaka S; Okamoto Y; Yamazaki M; Mitani N; Nakqjima Y; Fukui H
    Hepatogastroenterology; 2007 Dec; 54(80):2301-5. PubMed ID: 18265652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone levels and chronic liver cirrhosis.
    Toccafondi R; Maioli M; Palmas S
    Riv Crit Clin Med; 1970; 70(1):120-5. PubMed ID: 5527338
    [No Abstract]   [Full Text] [Related]  

  • 13. Lysosomal enzymes in sera and granulocytes of patients with chronic liver diseases.
    Fehér J; Toncsev H; Fehér E; Kiss A; Vasady A
    Int J Tissue React; 1981 Mar; 3(1):31-7. PubMed ID: 7287055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course.
    Tacke F; Trautwein C; Yagmur E; Hellerbrand C; Wiest R; Brenner DA; Schnabl B
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1256-64. PubMed ID: 17688666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases.
    De Fernandez MA; Clark A; Triger DR
    Clin Exp Immunol; 1987 Mar; 67(3):655-61. PubMed ID: 3608234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors (IGF) in liver disease: differential changes of IGF-I and IGF-II.
    Sheppard MS; Minuk GY; Bhaumick B; Bala RM
    Clin Invest Med; 1987 Mar; 10(2):49-53. PubMed ID: 3581545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
    Pagani A; Pranzo A; Sala N; Galante T
    Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of immunoreactive insulin, "big insulin" and the somatotropic hormone in cirrhotic patients with diabetes mellitus].
    Gragnoli G; Genazzani AR; Tanganelli I; Palazzuoli V; Felber JP
    Folia Endocrinol; 1974 Apr; 27(2):196-211. PubMed ID: 4406492
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis].
    Mangieri E; Tosti-Croce C; Tanzilli G; Barillà F; Nardi M; Poggi M; Ciavolella M; Farinelli A; Mangiaracina F; Campa PP
    Cardiologia; 1996 May; 41(5):449-53. PubMed ID: 8767634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
    Fisher L; Fisher A
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):513-20. PubMed ID: 17222588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.